Zurich Cantonal Bank
IGMS

Zurich Cantonal Bank’s IGM Biosciences IGMS Stock Holding History

Zurich Cantonal Bank’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-671
Closed -$20K – 2776
2021
Q4 		$20K Sell
671
-70
-9% -$3.48K ﹤0.01% 2857
2021
Q3 		$49K Buy
741
+4
+0.5% +$306 ﹤0.01% 2619
2021
Q2 		$61K Buy
737
+51
+7% +$3.78K ﹤0.01% 2402
2021
Q1 		$53K Buy
+686
New +$62.4K ﹤0.01% 2369

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Zurich Cantonal Bank's IGMS Position: Q1 2022 in Review

Zurich Cantonal Bank sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 671 shares — an estimated $20K sold.

Zurich Cantonal Bank first reported a position in IGMS in Q1 2021 and held it in 4 quarters. The position peaked at $61K in Q2 2021. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Zurich Cantonal Bank reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 671 IGM Biosciences shares in Q1 2022, an estimated $20K.
  • Zurich Cantonal Bank first reported a position in IGM Biosciences in Q1 2021 and held it in 4 quarters.
  • Zurich Cantonal Bank's IGM Biosciences position peaked at $61K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.